What is ISOPLEX®?
ISOPLEX® is a succinylated gelatin-based colloidal plasma substitute, which is formulated in a ‘balanced’ electrolyte solution.
Licensed therapeutic indication
ISOPLEX® is a colloidal plasma substitute indicated for the initial management of hypovolaemic shock caused by, for example, haemorrhage, acute trauma or surgery, burns, sepsis, peritonitis, pancreatitis or crush injury. ISOPLEX® may also be used in the initial treatment of blood loss during pregnancy where plasma volume replacement is needed.
Download the SPC - (PDF)
Download the Patient Information Leaflet (PDF)
ISOPLEX® enquiries
Movianto |
|
IS Pharma plc have divested ISOPLEX. For more information, please click here.